MicroRNAs in inflammatory lung disease--master regulators or target practice?
about
Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitizationMicroRNA Dysregulation in Cystic FibrosisRoles of microRNA-146a and microRNA-181b in regulating the secretion of tumor necrosis factor-α and interleukin-1β in silicon dioxide-induced NR8383 rat macrophagesHuman mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cellsIdentification of potential COPD genes based on multi-omics data at the functional level.Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis.Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patientsAn 11-nt sequence polymorphism at the 3'UTR of human SFTPA1 and SFTPA2 gene variants differentially affect gene expression levels and miRNA regulation in cell cultureCXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1/ERK, JNK, and AP-1 pathways.Epigenetics and chromatin remodeling play a role in lung diseaseAnalysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarctionThe roles of microRNAs on tuberculosis infection: meaning or myth?Proteogenomics of selective susceptibility to endotoxin using circulating acute phase biomarkers and bioassay development in sheep: a review.Systemic inflammation impairs respiratory chemoreflexes and plasticity.Integrating omics technologies to study pulmonary physiology and pathology at the systems level.The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating β-Catenin.MicroRNA-181b stimulates inflammation via the nuclear factor-κB signaling pathway in vitro.Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesisMicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis.IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation.Antisense oligonucleotide treatment enhances the recovery of acute lung injury through IL-10-secreting M2-like macrophage-induced expansion of CD4+ regulatory T cells.Attenuation of inflammatory mediator production by the NF-κB member RelB is mediated by microRNA-146a in lung fibroblasts.Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease.Role of microRNAs in lung development and pulmonary diseasesRNAi Therapeutic Platforms for Lung Diseases.Role of MicroRNAs in lung disease.MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression.MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway.Circulating microRNAs in patients with ST-elevation myocardial infarction.Translational medicine as a new clinical tool and application which improves metabolic diseases: perspectives from 2012 Sino-American symposium on clinical and translational medicine.Gene therapy for allergic airway diseases.The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.SLPI and inflammatory lung disease in females.MicroRNAs: Emerging Regulators of Immune-Mediated Diseases.Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases.MicroRNAs as potential biomarkers of smoking-related diseases.Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.The role of miRNAs in mast cells and other innate immune cells.
P2860
Q23921574-8FF29F13-D327-4D32-AF26-1D0D1CE63034Q26799762-EEEFEC9B-C6C6-4EA6-9464-3E0247B16DEEQ28389474-1FBFB295-A9BC-4796-AB58-83D4B014567BQ28535304-86985B60-5186-4DEB-928E-18E4222700C7Q31024506-4575D1E3-5E6C-424A-A61E-E84BFD613ACDQ31086074-C469100E-D2D2-459C-A10F-919C1B2BFDCEQ33579627-A592227E-D225-4674-8CEA-FF3282FCA6DCQ33840389-2F292F80-07E7-44B7-9B81-356AF3E87ECAQ34046726-CCF9192C-7FC8-4078-83D2-2C24A468E8A8Q34126445-BAC3676B-1306-4CDB-9767-C47C766C7253Q34280453-B7BE5747-87E5-4CF7-A86D-DD3CBC279309Q34510584-2E9B2955-72BA-4BD7-B28B-43D497101942Q34985202-5292B371-6FFE-4A1F-948E-FD80E0FC0489Q35104729-94BDBF42-EE5F-455F-994B-73D153D92067Q35212454-FD7DB60F-3372-4672-BDA7-3C6D6FDEDFF2Q35413415-EAD7260F-FCFC-444E-9484-9ED18B9F281CQ35816374-6F06ACF5-F01C-4144-BEE1-B0734E18FE68Q35951046-AF434324-C89A-4A5A-B8B3-07EB5CD0688AQ36081447-859E424E-5215-49A4-9D33-E252DCCBDFE4Q36275264-E0580C07-8F86-4790-8C76-BFF0B9B68CBAQ36323810-51F3B480-2A97-4005-B46F-970169644B3EQ36713991-791FA3C4-DC44-4174-A0AA-748E665560E1Q36748254-F032D574-432C-4DF8-AC7F-24742C5C7813Q36923917-44152E14-DDE8-4DF6-9214-9863FE8FB181Q37088341-99DA709B-1489-4B3C-BD60-CF7C46CD1B9CQ37133793-4BA80FA9-38C8-419E-B3C8-C890A4C2E7D8Q37277373-9C8F712E-5FE9-484E-9F8C-1CF0EEE3B659Q37374960-8F002518-4825-4D88-A17D-60199BB9A7ECQ37580729-AE5FE529-63F0-4961-AB09-84D13C61DD79Q37652831-AFBAE85D-3627-4D5D-A476-7ECEA3F65F46Q37672902-955B6BDA-5423-4298-8F0A-B93BDB271229Q37717478-4CB12A74-F040-45D7-81B4-66E9D7044E8DQ37829670-0C97830F-64D8-47AE-B525-1FC83E9E2346Q37933095-6E64B7CC-F481-4E2E-8E45-3E4E0953813DQ37936535-2697074A-FE86-4DDE-A327-2D4E2ED4E7CBQ37944359-E00B4B2D-131C-465B-8A37-B4F936047424Q37991391-A66D865E-B853-4A9D-992B-D3BD4A451FD0Q38052928-F53F479A-F500-48A9-AC58-817863BC68ECQ38082379-EF499073-F093-472F-A725-FDA096645D43Q38095494-880DD423-26B5-4CAD-82B0-FAB853C2F2B4
P2860
MicroRNAs in inflammatory lung disease--master regulators or target practice?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@en
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@nl
type
label
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@en
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@nl
prefLabel
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@en
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@nl
P2860
P921
P356
P1433
P1476
MicroRNAs in inflammatory lung disease--master regulators or target practice?
@en
P2093
Noel G McElvaney
P2860
P2888
P356
10.1186/1465-9921-11-148
P577
2010-10-28T00:00:00Z
P5875
P6179
1026437107